Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Transplantation(Electronic Edition) ›› 2021, Vol. 15 ›› Issue (05): 313-316. doi: 10.3877/cma.j.issn.1674-3903.2021.05.012

• Review • Previous Articles     Next Articles

Nonthyroidal illness syndrome related to heart transplantation and thyroid hormone replacement therapy

Chunlei Feng1, Jie Huang1,()   

  1. 1. Department of Heart Failure and Transplantation, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
  • Received:2021-06-08 Online:2021-10-25 Published:2022-01-29
  • Contact: Jie Huang

Abstract:

Nonthyroidal illness syndrome (NTIS) is common in patients undergoing cardiac surgery which is associated with the prognosis of critically ill patients, and thyroid hormone replacement therapy is considered unnecessary for most patients without cardiac dysfunction. But heart transplantation has its particularity. The heart transplantation donors are come from donation after brain death, the level of thyroid hormone of donors degrades rapidly after brain death. Most of the heart transplantation recipients are patients with end-stage heart failure, who are more likely to be presented with NTIS and other thyroid dysfunction before transplantation. There remains debate about the potential benefits of thyroid hormone supplementation when considered heart transplantation. Nonthyroidal illness syndrome related to heart transplantation and thyroid hormone replacement therapy is reviewed in this paper.

Key words: Heart transplantation, Thyroid hormone, Nonthyroidal illness syndrome

京ICP 备07035254号-20
Copyright © Chinese Journal of Transplantation(Electronic Edition), All Rights Reserved.
Tel: 0571-87236589 E-mail: yizhi@zju.edu.cn
Powered by Beijing Magtech Co. Ltd